Quick Takeaways
- Woodline Partners LP filed SCHEDULE 13G for Tenaya Therapeutics, Inc. Common Stock, par value $0.0001 per share (TNYA).
- Disclosed ownership: 6.8%.
- Date of event: 31 Mar 2025.
Woodline Partners LP - 31 Mar 2025 SCHEDULE 13G Report for Tenaya Therapeutics, Inc. Common Stock, par value $0.0001 per share (TNYA)
- Filing Manager
- Woodline Partners LP
- Reporting Manager
- Woodline Partners LP
- Symbol
- TNYA
- Shares outstanding
- 87,002,456 shares
- Disclosed Ownership
- 5,916,167 shares
- Ownership
- 6.8%
- Form type
- SCHEDULE 13G
- Filing time
- 15 May 2025, 09:32:51 UTC
- Date of event
- 31 Mar 2025
- Next filing
- 14 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Woodline Partners LP disclosed 6.8% ownership in Tenaya Therapeutics, Inc. Common Stock, par value $0.0001 per share (TNYA) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 May 2025, 09:32.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Woodline Partners LP | 6.8% | 5,916,167 | 0 | 5,916,167 | /s/ Erin Mullen | Erin Mullen, General Counsel & Chief Compliance Officer |